We previously reported that cGAMP and other STING ligands function as type 2 adjuvants, characterized by the induction of serum IgE levels, suggesting that cGAMP may be one of the endogenous factors (adjuvants) for the promotion of type 2 immune responses and allergic asthma. This evidence concerns the gene IGHE and allergic asthma.